Table 2 Characteristics of patients with large-cell carcinoma and neuroendocrine marker expression as well as with large-cell carcinoma and neuroendocrine morphology only.

1

M

41

II B

LL l

60

LCCNM

† intrapulmonary recurrence *

2

M

57

I B

LL r

96

LCCNM

Disease-free

3

M

76

I B

LL l

30

LCCNM

† intrapulmonary recurrence *

4

M

74

III A

UL r

11

LCCNM

† intrapulmonary recurrence *

5

M

61

I A

S 4/5 l

18

LCNEC

Disease-free

6

M

66

I B

Pneumonectomy l

26

LCNEC

† distant metastases

7

M

75

I A

UL l

24

LCNEC

Disease-free

8

M

67

I B

LL l

20

LCNEC

† brain metastases

9

M

70

II B

Pneumonectomy r

12

LCNEC

† bone metastases

10

F

58

IV

UL l

20

LCNEC

† bone metastases

11

M

80

I A

S 8 r

19

LCNEC

Disease-free

12

M

57

III B

Bifurcation

2

LCNEC

Disease-free